Cargando…
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
Pancreatic cancer is an aggressive malignancy with increasing incidence. Pancreatic ductal adenocarcinoma (PDAC) accounts for > 90% of pancreatic cancer diagnoses, while other exocrine tumors are much rarer. In this review, we have focused on two rare cancers of the exocrine pancreas: adenosquamo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400043/ https://www.ncbi.nlm.nih.gov/pubmed/37538977 http://dx.doi.org/10.20517/2394-4722.2022.106 |